Mydayis

Help at Hand Patient Assistance Program Patient Guide: How to Get Mydayis at Low or No Cost

Mydayis (mixed amphetamine salts extended-release) is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) in patients aged 13 years and older. The Help at Hand Patient Assistance Program from Takeda Pharmaceuticals provides eligible patients with low or no-cost access to Mydayis if they lack insurance or have insufficient coverage.[1][7]

About Mydayis

Mydayis is an extended-release capsule containing mixed salts of a single-entity amphetamine, designed as a central nervous system stimulant.[7] It uses a unique triple-bead release system that delivers the medication in three phases: immediate release upon taking it (effects felt in 30-60 minutes), a second release around 4 hours later for midday coverage, and a third around 8 hours for late afternoon and evening support. This allows it to last up to 16 hours with just one morning dose.[2][5][8]

Approved by the FDA for ADHD in adolescents (13-17 years) and adults, Mydayis helps improve attention, reduce impulsivity, and manage hyperactivity.[1][7] Typical starting doses are 12.5 mg once daily for both adults and pediatrics (13-17), with weekly increases of 12.5 mg as needed, up to a maximum of 50 mg for adults and 25 mg for pediatrics. Lower doses apply for severe renal impairment (max 25 mg/day adults, 12.5 mg/day pediatrics), and it's not recommended for end-stage renal disease.[3][7]

Important safety notes: Mydayis is a Schedule II controlled substance due to abuse potential. It's contraindicated in those with known hypersensitivity to amphetamines, recent use of MAOIs (within 14 days), or certain other conditions. Common side effects include insomnia, decreased appetite, and increased heart rate. Always take as prescribed, consistently with or without food, and avoid alcohol which may speed release.[1][4][7]

Mydayis is often compared to Adderall XR (lasts 8-12 hours) but provides longer coverage. It's taken long-term if effective and safe.[3][6][8]

Who Qualifies for Help at Hand?

The Help at Hand Patient Assistance Program supports patients who have no insurance or insufficient insurance coverage for their medications.[program details] It's aimed at those facing financial hardship affording prescriptions like Mydayis. While specific income thresholds are not publicly detailed (check the application for updates), patient assistance programs like this typically target uninsured, underinsured, or low-income individuals meeting federal poverty guidelines (often 400-500% of FPL, varying by household size and program).

Key eligibility factors:

• U.S. resident with a valid prescription for Mydayis.
• Diagnosis of ADHD (ages 13+).
• No or inadequate prescription insurance.
• Financial need (income verification often required).

Patients with Medicare, Medicaid, or certain commercial insurance may have restrictions; the program prioritizes those without viable coverage options.[program details]

Income Eligibility Breakdown

Specific income thresholds for Help at Hand are not listed in available resources, so eligibility is determined during application with proof of income.[program details] Below is a general table based on common patient assistance standards (e.g., 400-500% Federal Poverty Level or FPL for 2026; verify with program as limits fluctuate). Use this as a guide—contact the program for exact criteria.

Note: FPL estimates for 2026; programs may adjust. Provide tax returns, pay stubs, or benefit statements.[program details]

Insurance Requirements

The program requires no insurance or insufficient insurance coverage. If you have commercial insurance but face high copays/deductibles making Mydayis unaffordable, you may qualify as underinsured. Medicare Part D or Medicaid patients are often ineligible, as government programs typically exclude them from manufacturer assistance. Confirm your insurance status during application—provide proof like denial letters or Explanation of Benefits (EOB).[program details][7]

Step-by-Step Application Process

Help at Hand offers multiple application methods for flexibility.[program details]

1. Gather Documents: Prescription from your doctor, proof of income (W-2, tax return, pay stubs), proof of residency, insurance status (if any), and doctor's contact info. Photo ID may be needed.

2. Choose Method:

   • Online: Visit https://www.helpathandpap.com to start. Create an account, upload docs, and submit.[program details]
   • Phone: Call (877) 825-3327 (Mon-Fri, typical business hours) for assistance or verbal application.[program details]
   • Mail/Fax: Download forms from the website and send as instructed.

3. Doctor Involvement: Your prescriber must complete a portion confirming medical necessity.

4. Submit: Review and send. You'll get a confirmation number.

5. Follow Up: Track status online or by phone.

Applications are free; approval means free or discounted Mydayis shipped to you or your doctor.

Timeline and Delivery

Processing time varies (typically 2-4 weeks, but not specified—call for updates).[program details] Expect notification by mail/email/phone. If approved, medication is delivered directly to your home or pharmacy (details confirmed post-approval). Initial supply may cover 1-3 months; refills require reapplication or renewal.[program details]

Alternatives if Denied

• Appeal: Contact the program with additional docs.
• Other PAPs: NeedyMeds.org or RxAssist.org list ADHD med programs.
• Generic Options: No generic Mydayis yet; consider Adderall XR or other amphetamines if appropriate.[2][8]
• State Programs: Check Medicaid or ADHD-specific aid.
• Copay Cards: Takeda may offer savings for insured (separate from PAP).
• Discuss with Doctor: Switch to lower-cost stimulants like generic methylphenidate.

Disclaimer

This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change—always verify directly with Help at Hand at (877) 825-3327 or https://www.helpathandpap.com. Not medical advice; consult your healthcare provider for treatment decisions. Takeda reserves rights to modify/discontinue the program. Word count: 1028.